allyl isothiocyanate has been researched along with urb 597 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Boa, AN; Chandrabalan, A; McPhillie, MJ; Morice, AH; Sadofsky, LR | 1 |
| Banke, TG; Chaplan, SR; Wickenden, AD | 1 |
1 review(s) available for allyl isothiocyanate and urb 597
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
2 other study(ies) available for allyl isothiocyanate and urb 597
| Article | Year |
|---|---|
N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
Topics: Animals; Calcium Signaling; Cinnamates; Guinea Pigs; HEK293 Cells; Humans; Male; Molecular Docking Simulation; ortho-Aminobenzoates; Structure-Activity Relationship; TRPA1 Cation Channel | 2019 |
Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
Topics: Animals; Benzamides; Benzoxazoles; Calcium; Calcium Channels; Carbamates; Cell Membrane; Cell Membrane Permeability; CHO Cells; Cricetinae; Cricetulus; Dogs; Dose-Response Relationship, Drug; Farnesol; Humans; Ion Channel Gating; Isothiocyanates; Kinetics; Meglumine; Membrane Transport Modulators; Nerve Tissue Proteins; Purinergic P2 Receptor Agonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Salicylates; Transfection; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPM Cation Channels; TRPV Cation Channels | 2010 |